Caplin Point Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Caplin Point Laboratories Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.71 billion Indian Rupees [US$79.08 million]
Novartis India Limited
(5.64 billion Indian Rupees [US$78.10 million]
of which 100%
was Pharmaceuticals), and
Neuland Laboratories Limited
(5.27 billion Indian Rupees [US$73.05 million]
Caplin Point Laboratories Limited reported sales of 5.40 billion Indian Rupees (US$74.77 million)
March of 2018.
increase of 34.4%
versus 2017, when the company's sales were 4.02 billion Indian Rupees.
Sales at Caplin Point Laboratories Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 325%).